학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 203건 | 목록 1~20
Academic Journal
Redondo-Pedraza J; Tumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Santamaría PG; Tumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Sanchez-Juan A; Tumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Jimenez M; Tumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Rocha AS; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.; Soria-Alcaide G; Tumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Terrón-Bautista J; Tumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Álvarez R; Bioinformatics Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; López V; Tumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Graña-Castro O; Bioinformatics Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA-Nemesio Díez), Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Caleiras E; Histopathology Core Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Ximénez-Embún P; Proteomics Core Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Bergholtz H; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Dalal H; Department of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK.; Gray GK; Department of Cell Biology, Harvard Medical School (HMS), Boston, MA, 02115, USA.; Isasa M; Proteomics Core Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Sørlie T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Khaled WT; Department of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK.; Cortés-Ledesma F; Tumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Mueller CG; CNRS UPR 3572, Immunologie, Immunopathologie et Chimie Thérapeutique, Université de Strasbourg, Strasbourg, France.; González-Suárez E; Tumor Biology and Immunology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain. egonzalez@cnio.es.; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain. egonzalez@cnio.es.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Hergueta-Redondo M; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Sánchez-Redondo S; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Hurtado B; Cancer Cell Cycle Group, Preclinical & Translational Research Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Santos V; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Pérez-Martínez M; Confocal Microscopy Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Ximénez-Embún P; Proteomics Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; McDowell SAC; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.; Mazariegos MS; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Division of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.; Lund Stem Cell Center (SCC), Lund University, Lund, Sweden.; Mata G; Confocal Microscopy Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Department of Mathematics and Computer Science, University of La Rioja, La Rioja, Spain.; Torres-Ruiz R; Molecular Cytogenetics Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnologicas (CIEMAT), Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigacion Sanitaria Fundacion Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Rodríguez-Perales S; Molecular Cytogenetics Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Martínez L; Flow Cytometry Core Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Graña-Castro O; Bioinformatics Unit, Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA-Nemesio Díez), Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, 28925, Alcorcón, Spain.; Megias D; Confocal Microscopy Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Advanced Optical Microscopy - ISCIII Madrid, Madrid, Spain.; Quail D; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.; Quintela-Fandino M; Breast Cancer Clinical Research Unit, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain.; Medical Oncology, Hospital de Fuenlabrada, Madrid, Spain.; Peinado H; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain. hpeinado@cnio.es.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Sayago C; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Sánchez-Wandelmer J; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; García F; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Hurtado B; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Cancer Cell Cycle group, Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain.; Lafarga V; Genomic Instability Group, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Prieto P; Mouse Genome Editing Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Zarzuela E; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Ximénez-Embún P; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Ortega S; Mouse Genome Editing Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Megías D; Confocal Microscopy Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Fernández-Capetillo O; Genomic Instability Group, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Malumbres M; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Cancer Cell Cycle group, Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), 08010, Barcelona, Spain.; Munoz J; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain. javier.munozperalta@osakidetza.eus.; Cell Signaling and Clinical Proteomics Group, Biocruces Bizkaia Health Research Institute, 48903, Barakaldo, Spain. javier.munozperalta@osakidetza.eus.; Ikerbasque, Basque foundation for science, 48011, Bilbao, Spain. javier.munozperalta@osakidetza.eus.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Benito-Martin A; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health and the Meyer Cancer Center, Weill Cornell Medical College, New York, New York, USA.; Universidad Alfonso X El Sabio, Facultad de Medicina, Unidad de Investigación Biomédica, Madrid, Spain.; Nogués L; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health and the Meyer Cancer Center, Weill Cornell Medical College, New York, New York, USA.; Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Hergueta-Redondo M; Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Castellano-Sanz E; Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Garvin E; Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Cioffi M; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health and the Meyer Cancer Center, Weill Cornell Medical College, New York, New York, USA.; Sola-Castrillo P; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health and the Meyer Cancer Center, Weill Cornell Medical College, New York, New York, USA.; Buehring W; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health and the Meyer Cancer Center, Weill Cornell Medical College, New York, New York, USA.; Ximénez-Embún P; Proteomics Unit-ProteoRed-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Muñoz J; Proteomics Unit-ProteoRed-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Matei I; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health and the Meyer Cancer Center, Weill Cornell Medical College, New York, New York, USA.; Villanueva J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Peinado H; Microenvironment and Metastasis Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0374672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2567 (Electronic) Linking ISSN: 00192805 NLM ISO Abbreviation: Immunology Subsets: MEDLINE
Academic Journal
Boix O; Cellular Plasticity and Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Martinez M; Cellular Plasticity and Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Vidal S; Centro de Investigación en Medicina Molecular (CIMUS), Universidad de Santiago de Compostela and Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela, Spain.; Giménez-Alejandre M; Cellular Plasticity and Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Palenzuela L; Cellular Plasticity and Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Lorenzo-Sanz L; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Quevedo L; Instituto de Biomedicina y Biotecnología de Cantabria, Universidad de Cantabria - CSIC, Santander, Spain.; Moscoso O; Department of Pathology, Vall d'Hebron University Hospital, Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona and Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Barcelona, Spain.; Ruiz-Orera J; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Ximénez-Embún P; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Ciriaco N; Department of Pathology, Vall d'Hebron University Hospital, Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona and Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Barcelona, Spain.; Nuciforo P; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Stephan-Otto Attolini C; Bioinformatics-Biostatistics Unit, Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Albà MM; IMIM - Hospital del Mar Medical Research Institute, Barcelona, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.; Muñoz J; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Tian TV; Noncolorectal Gastrointestinal Cancer Translational Research Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Varela I; Instituto de Biomedicina y Biotecnología de Cantabria, Universidad de Cantabria - CSIC, Santander, Spain.; Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Ramón Y Cajal S; Department of Pathology, Vall d'Hebron University Hospital, Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona and Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Barcelona, Spain.; Muñoz P; Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Rivas C; Centro de Investigación en Medicina Molecular (CIMUS), Universidad de Santiago de Compostela and Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela, Spain.; Departamento de Biología Molecular y Celular, Centro Nacional de Biotecnología (CNB), CSIC, Darwin 3, 28049, Madrid, Spain.; Abad M; Cellular Plasticity and Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. mabad@vhio.net.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Sanz-Castillo B; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Hurtado B; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Vara-Ciruelos D; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; El Bakkali A; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Hermida D; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Salvador-Barbero B; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Martínez-Alonso D; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; González-Martínez J; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Santiveri C; Spectroscopy and Nuclear Magnetic Resonance Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Campos-Olivas R; Spectroscopy and Nuclear Magnetic Resonance Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Ximénez-Embún P; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Muñoz J; Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Álvarez-Fernández M; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Oviedo, Spain.; Malumbres M; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Ximénez-Embún, P.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어